NasdaqCM - Nasdaq Real Time Price • USD
ProPhase Labs, Inc. (PRPH)
As of 11:50 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -0.28 | -0.24 | -0.82 | 0.48 |
| Low Estimate | -0.41 | -0.41 | -1.55 | 0.48 |
| High Estimate | -0.15 | -0.08 | -0.1 | 0.48 |
| Year Ago EPS | 0.03 | -0.2 | -0.98 | -0.82 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | 9.86M | 11.17M | 54.78M | 138.26M |
| Low Estimate | 4M | 4M | 22M | 138.26M |
| High Estimate | 15.72M | 18.35M | 87.57M | 138.26M |
| Year Ago Sales | 19.3M | 14.14M | 45.24M | 54.78M |
| Sales Growth (year/est) | -48.90% | -21.00% | 21.10% | 152.40% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.14 | -0.19 | -0.26 |
| EPS Actual | 0.03 | -0.2 | -0.3 | -0.51 |
| Difference | 0.12 | -0.06 | -0.11 | -0.25 |
| Surprise % | 133.30% | -42.90% | -57.90% | -96.20% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.28 | -0.24 | -0.82 | 0.48 |
| 7 Days Ago | -0.41 | -0.41 | -1.55 | 0.53 |
| 30 Days Ago | -0.41 | -0.41 | -1.55 | 0.53 |
| 60 Days Ago | -0.16 | -0.12 | -0.37 | 0.53 |
| 90 Days Ago | -0.16 | -0.12 | -0.37 | 0.53 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PRPH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -1,033.30% | -- | -- | 1.50% |
| Next Qtr. | -20.00% | -- | -- | 11.40% |
| Current Year | 16.30% | -- | -- | 5.20% |
| Next Year | 158.50% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | 389.90% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/21/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/10/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/2/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/12/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 3/8/2023 |
Related Tickers
BIAF bioAffinity Technologies, Inc.
2.3350
-4.69%
VNRX VolitionRx Limited
0.8601
+7.51%
DRIO DarioHealth Corp.
1.4700
-2.02%
SERA Sera Prognostics, Inc.
9.84
-1.99%
IZOZF Izotropic Corporation
0.0930
-10.54%
GENE Genetic Technologies Limited
2.2000
-2.22%
IQV IQVIA Holdings Inc.
233.12
-3.21%
CDNA CareDx, Inc
7.63
-4.39%
RDNT RadNet, Inc.
48.48
-0.39%
ISPC iSpecimen Inc.
0.2927
+5.62%